AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development
Employees: 11-50
Total raised: $162M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | BioRock Ve... | biorockven... |
| - | Flucas Ven... | flucasvc.c... |
| 09.01.2022 | RA Capital... | racap.com |
| - | Adjuvant C... | adjuvantca... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.08.2023 | - | $70M | - |
| 07.01.2022 | Series B | $80M | RA Capital... |
| 21.11.2019 | Series A | $12M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 22.03.2024 | Brii Biosciences Provides Corporate Update and Reports Full-... | Transitioning HBV cure programs into multiple late-stage combination studies with interim results th... | en.prnasia... |
| 15.08.2023 | AN2 Therapeutics Announces Pricing of $70.0 Million Underwri... | - | tcgcrossov... |
| 29.09.2022 | NIH Awards Contract to AN2 Therapeutics Valued Up to $17.8 M... | Non-dilutive funding will drive synergies with existing epetraborole development program for NTM lun... | globenewsw... |
| 07.01.2022 | AN2 Therapeutics Closes $80M Series B Financing | AN2 Therapeutics, Inc., a Menlo Park, CA-based clinical-stage biopharmaceutical company focused on d... | finsmes.co... |
| 21.11.2019 | AN2 Therapeutics Raises $12M in Series A Funding | AN2 Therapeutics, Inc., a Menlo Park, Calif.-based biopharmaceutical company focused on the research... | finsmes.co... |
| 21.11.2019 | AN2 Therapeutics Secures $12M Series A | MENLO PARK, CA, AN2 Therapeutics today announced that it has raised $12 million in a Series A fina... | vcnewsdail... |
| - | AN2 Therapeutics’ IPO raises $69M to take antibiotic from Pf... | Economic concerns have halted or at least delayed the plans of many companies to go public, but one ... | medcitynew... |